Targeting ZNF638 activates antiviral immune responses and potentiates immune checkpoint inhibition in glioblastoma.
Seetharam D, Chandar J, Ramsoomair CK, Desgraves JF, Medina AA, Hudson AJ, Amidei A, Castro JR, Govindarajan V, Wang S, Zhang Y, Sonabend AM, Valdez MJM, Maric D, Govindarajan V, Rivas SR, Lu VM, Tiwari R, Sharifi N, Thomas E, Alexander M, DeMarino C, Johnson K, De La Fuente MI, Nasany RA, Noviello TMR, Ivan ME, Komotar RJ, Iavarone A, Nath A, Heiss J, Ceccarelli M, Chiappinelli KB, Figueroa ME, Bayik D, Shah AH.
Seetharam D, et al. Among authors: govindarajan v.
bioRxiv [Preprint]. 2024 Oct 15:2024.10.13.618076. doi: 10.1101/2024.10.13.618076.
bioRxiv. 2024.
PMID: 39464150
Free PMC article.
Preprint.